Wearable Health Solutions, Inc. (WHSI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 2.76 Million USD | 62.37% |
| 2022 | 1.7 Million USD | -35.91% |
| 2021 | 2.65 Million USD | 52.71% |
| 2020 | 1.74 Million USD | 40.24% |
| 2019 | 1.24 Million USD | 9.35% |
| 2018 | 1.13 Million USD | 7.53% |
| 2017 | 1.05 Million USD | 23.15% |
| 2016 | 857.59 Thousand USD | 80.82% |
| 2015 | 474.29 Thousand USD | 1434.53% |
| 2014 | 30.9 Thousand USD | -96.56% |
| 2013 | 898.33 Thousand USD | 357.58% |
| 2012 | 196.32 Thousand USD | -6.69% |
| 2011 | 210.39 Thousand USD | -17.88% |
| 2010 | 256.21 Thousand USD | -64.87% |
| 2009 | 729.3 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 2.5 Million USD | -9.5% |
| 2024 Q2 | 2.36 Million USD | -5.38% |
| 2023 FY | 2.76 Million USD | 62.37% |
| 2023 Q1 | 1.73 Million USD | 1.68% |
| 2023 Q4 | 2.76 Million USD | 42.22% |
| 2023 Q3 | 1.94 Million USD | 1.07% |
| 2023 Q2 | 1.92 Million USD | 11.1% |
| 2022 FY | 1.7 Million USD | -35.91% |
| 2022 Q1 | 2.28 Million USD | -14.23% |
| 2022 Q2 | 1.73 Million USD | -23.76% |
| 2022 Q3 | 1.59 Million USD | -8.07% |
| 2022 Q4 | 1.7 Million USD | 6.61% |
| 2021 Q3 | 2.73 Million USD | 0.0% |
| 2021 FY | 2.65 Million USD | 52.71% |
| 2021 Q4 | 2.65 Million USD | -2.78% |
| 2021 Q1 | 2.34 Million USD | 34.73% |
| 2020 Q3 | 1.55 Million USD | 10.19% |
| 2020 FY | 1.74 Million USD | 40.24% |
| 2020 Q1 | 1.36 Million USD | 9.8% |
| 2020 Q2 | 1.41 Million USD | 3.67% |
| 2020 Q4 | 1.74 Million USD | 11.81% |
| 2019 Q3 | 1.23 Million USD | 0.0% |
| 2019 FY | 1.24 Million USD | 9.35% |
| 2019 Q2 | 1.23 Million USD | 0.0% |
| 2019 Q1 | 1.23 Million USD | 8.66% |
| 2019 Q4 | 1.24 Million USD | 0.64% |
| 2018 Q1 | 1.12 Million USD | 6.25% |
| 2018 FY | 1.13 Million USD | 7.53% |
| 2018 Q4 | 1.13 Million USD | 0.54% |
| 2018 Q3 | 1.12 Million USD | 1.76% |
| 2018 Q2 | 1.11 Million USD | -1.08% |
| 2017 Q4 | 1.05 Million USD | -0.64% |
| 2017 Q3 | 1.06 Million USD | 76.46% |
| 2017 Q2 | 602.37 Thousand USD | -33.29% |
| 2017 Q1 | 903.01 Thousand USD | 5.3% |
| 2017 FY | 1.05 Million USD | 23.15% |
| 2016 Q4 | 857.59 Thousand USD | 5.1% |
| 2016 Q2 | 499.9 Thousand USD | 1.58% |
| 2016 Q1 | 492.14 Thousand USD | 3.76% |
| 2016 Q3 | 815.98 Thousand USD | 63.23% |
| 2016 FY | 857.59 Thousand USD | 80.82% |
| 2015 Q3 | 396.6 Thousand USD | 44.22% |
| 2015 Q4 | 474.29 Thousand USD | 19.59% |
| 2015 Q1 | 111.9 Thousand USD | 262.07% |
| 2015 FY | 474.29 Thousand USD | 1434.53% |
| 2015 Q2 | 275 Thousand USD | 145.74% |
| 2014 Q3 | 45.9 Thousand USD | -45.93% |
| 2014 FY | 30.9 Thousand USD | -96.56% |
| 2014 Q4 | 30.9 Thousand USD | -32.67% |
| 2014 Q2 | 84.9 Thousand USD | -91.06% |
| 2014 Q1 | 950.01 Thousand USD | 5.75% |
| 2013 Q1 | 2.79 Million USD | 1326.04% |
| 2013 Q2 | 228.55 Thousand USD | -91.84% |
| 2013 Q3 | 258.38 Thousand USD | 13.05% |
| 2013 Q4 | 898.33 Thousand USD | 247.67% |
| 2013 FY | 898.33 Thousand USD | 357.58% |
| 2012 Q2 | 249.95 Thousand USD | 12.97% |
| 2012 Q3 | 712.27 Thousand USD | 184.96% |
| 2012 Q4 | 196.32 Thousand USD | -72.44% |
| 2012 FY | 196.32 Thousand USD | -6.69% |
| 2012 Q1 | 221.25 Thousand USD | 5.16% |
| 2011 Q1 | 271.76 Thousand USD | 6.07% |
| 2011 Q2 | 282.88 Thousand USD | 4.09% |
| 2011 Q4 | 210.39 Thousand USD | -25.43% |
| 2011 FY | 210.39 Thousand USD | -17.88% |
| 2011 Q3 | 282.13 Thousand USD | -0.27% |
| 2010 Q2 | 538.89 Thousand USD | 29.12% |
| 2010 FY | 256.21 Thousand USD | -64.87% |
| 2010 Q4 | 256.21 Thousand USD | -57.54% |
| 2010 Q3 | 603.34 Thousand USD | 11.96% |
| 2010 Q1 | 417.37 Thousand USD | -42.77% |
| 2009 Q3 | 467.5 Thousand USD | -81.3% |
| 2009 Q4 | 729.3 Thousand USD | 56.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q2 | 2.5 Million USD | 0.0% |
| 2009 FY | 729.3 Thousand USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 500 Thousand USD | -453.474% |
| Ansell Limited | 855.59 Million USD | 99.677% |
| Ansell Limited | 857.2 Million USD | 99.677% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 22.41 Million USD | 87.652% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 20.93 Thousand USD | -13118.868% |
| Psykey, Inc. | 1.01 Million USD | -173.834% |
| ConvaTec Group Plc | 1.31 Billion USD | 99.789% |
| ConvaTec Group Plc | 1.31 Billion USD | 99.789% |
| Encision Inc. | 1.33 Million USD | -107.573% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | -19.866% |
| Innovative MedTech Inc. | 1.87 Million USD | -47.34% |
| LifePoint, Inc. | 446.74 Thousand USD | -519.459% |
| Medite Cancer Diagnostics, Inc. | 5.39 Million USD | 48.697% |
| Paradigm Medical Industries, Inc. | 2.18 Million USD | -26.422% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | - USD | -Infinity% |
| Reflect Scientific, Inc. | 242.64 Thousand USD | -1040.506% |
| SmileDirectClub, Inc. | 871.79 Million USD | 99.683% |
| Sector 10, Inc. | 164 Thousand USD | -1587.421% |
| Shandong Weigao Group Medical Polymer Company Limited | 674.01 Million USD | 99.589% |
| SheerVision, Inc. | 75 Thousand USD | -3589.827% |
| United Health Products, Inc. | 755.98 Thousand USD | -266.06% |
| Vasamed, Inc. | 23.45 Thousand USD | -11701.151% |
| Yubo International Biotech Limited | 790.49 Thousand USD | -250.079% |